Published in N Engl J Med on April 20, 1978
Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet (2008) 7.07
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A (1998) 3.14
CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76
Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis (1991) 2.66
Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet (2002) 2.47
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis (2005) 2.35
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol (2014) 2.28
Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol (2013) 2.20
Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest (1992) 2.09
High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci U S A (2012) 2.03
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis (1982) 1.99
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med (1996) 1.80
Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol (2012) 1.78
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis (2002) 1.74
Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med (1978) 1.71
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res (1999) 1.63
DR antigens and rheumatoid arthritis: a study of two populations. Br Med J (Clin Res Ed) (1981) 1.59
Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol (2010) 1.58
Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis (1985) 1.56
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A (2002) 1.55
A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet (2008) 1.53
Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A (1989) 1.52
Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J Clin Invest (2006) 1.49
The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: a lesson learned from tic-tac-toe. Arthritis Rheum (2008) 1.48
Smoking, lung function, and rheumatoid factors. Ann Rheum Dis (1990) 1.43
Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest (1979) 1.38
Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest (1994) 1.37
Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis. J Clin Invest (1984) 1.37
Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med (1989) 1.37
Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J Clin Invest (1986) 1.34
Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun (2008) 1.32
Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis (1986) 1.32
Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis (2012) 1.30
Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A (2007) 1.29
Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J Exp Med (1995) 1.28
Familial rheumatoid arthritis: linkage of HLA to disease susceptibility locus in four families where proband presented with juvenile rheumatoid arthritis. J Clin Invest (1980) 1.26
Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci U S A (1992) 1.26
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet (1996) 1.23
Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis (1983) 1.23
The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest (1992) 1.23
The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest (1992) 1.22
HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22
Genetics of rheumatoid arthritis: what have we learned? Immunogenetics (2011) 1.21
Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest (1980) 1.21
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol (1988) 1.20
Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed (2005) 1.19
Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet (1995) 1.19
HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis (1981) 1.17
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments. Ann Rheum Dis (1998) 1.14
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis. J Clin Invest (1986) 1.14
Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis (1987) 1.14
Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther (2008) 1.14
T cell receptor V beta gene bias in rheumatoid arthritis. J Clin Invest (1993) 1.12
Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and proteus/serratia membrane haemolysins. Ann Rheum Dis (1992) 1.11
HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis (1982) 1.11
Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol (2008) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice. Proc Natl Acad Sci U S A (1989) 1.10
Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis. Am J Hum Genet (1993) 1.07
Association of MHC antigens with susceptibility to and severity of rheumatoid arthritis in multicase families. Ann Rheum Dis (1985) 1.07
Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune Dis (2012) 1.07
TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin Exp Immunol (1999) 1.06
Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints. Clin Exp Immunol (1980) 1.06
Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family. J Clin Invest (1988) 1.06
Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. Ann Rheum Dis (1993) 1.05
Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis (2005) 1.04
Studies of T-cell activation in chronic inflammation. Arthritis Res (2002) 1.04
Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A (1990) 1.03
Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet (2004) 1.01
Genome-wide gene-based association study. BMC Proc (2009) 1.00
Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment. Ann Rheum Dis (1988) 1.00
Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest (1997) 0.99
Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology (1996) 0.99
A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4. J Clin Invest (1997) 0.98
HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis (1987) 0.98
Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition. J Clin Invest (1990) 0.97
Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4. Rheumatol Int (1984) 0.95
Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis. Clin Exp Immunol (1984) 0.95
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. Blood (2014) 0.94
Immunogenetic heterogeneity of seronegative rheumatoid arthritis and the antiperinuclear factor. Ann Rheum Dis (1990) 0.94
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol (2015) 0.93
The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest (2010) 0.93
The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes. Arthritis Res (2000) 0.93
Lack of influence of non-inherited maternal HLA-DR alleles on susceptibility to rheumatoid arthritis. Ann Rheum Dis (1995) 0.93
HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut (1985) 0.92
Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men. Arthritis Res (2000) 0.92
HLA studies in IgM rheumatoid-factor-positive arthritis of childhood. Ann Rheum Dis (1983) 0.91
HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.91
New insights into the functional role of the rheumatoid arthritis shared epitope. FEBS Lett (2011) 0.89
Molecular analysis of HLA-DR beta and DQ beta polymorphism in Chinese with rheumatoid arthritis. Ann Rheum Dis (1993) 0.89
Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology (2008) 0.89
The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens. Clin Exp Immunol (1993) 0.88
Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis. Ann Rheum Dis (2005) 0.88
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest (1990) 0.88
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest (1976) 2.84
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A (1980) 2.61
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
A new antigen system expressed in human endothelial cells. J Clin Invest (1977) 1.79
Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics (1998) 1.43
Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest (1979) 1.38
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
The human immune response region (HLA-D) and disease susceptibility. Immunol Rev (1983) 1.24
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. J Immunol (1983) 1.22
HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 1.20
Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol (2000) 1.18
HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplant Proc (1977) 1.15
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry (2000) 1.13
HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.12
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Immunogenetic factors in preeclampsia and eclampsia. Erythrocyte, histocompatibility, and Y-dependent antigens. JAMA (1976) 1.11
Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease. J Clin Invest (1974) 1.11
DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol (1992) 1.10
Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol (1986) 1.09
Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol (1999) 1.08
Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol (1984) 1.06
Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets. Immunogenetics (1982) 1.06
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol (2001) 1.04
HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol (1988) 1.04
Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum (1974) 1.03
Family-aided assertive community treatment: a comprehensive rehabilitation and intensive case management approach for persons with schizophrenic disorders. New Dir Ment Health Serv (1992) 1.03
Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus. Arthritis Rheum (1972) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Contribution of family, cognitive and clinical dimensions to long-term outcome in schizophrenia. Schizophr Res (1992) 1.00
Monoclonal antibodies against human monocytes. II. Recognition of two distinct cell surface molecules. Scand J Immunol (1982) 0.97
Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol (1985) 0.97
Lymphocyte and platelet autoantibodies in S.L.E. Lancet (1971) 0.97
Restriction fragment length polymorphism of the gene encoding the alpha chain of the human T cell receptor. J Exp Med (1985) 0.96
Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med (1988) 0.96
Development of immunological memory during the primary immune response. Nature (1967) 0.95
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Juvenile arthritis and autoimmunity to type II collagen. Arthritis Rheum (2001) 0.94
Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med (1988) 0.94
High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest (1981) 0.93
Genetic markers for susceptibility to endemic Brazilian pemphigus foliaceus (Fogo Selvagem) in Xavante Indians. Tissue Antigens (1993) 0.93
HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice. Am J Transplant (2009) 0.93
HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens (1991) 0.93
Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens (1993) 0.93
Successful kidney trasnplant in patient with positive crossmatch due to autoantibodies. Transplantation (1976) 0.92
Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production. Clin Immunol Immunopathol (1983) 0.92
Study of HLA antigens in ten multiple-case rheumatoid arthritis families. J Rheumatol (1984) 0.91
Dissimilar evolution of B-locus versus A-locus and class II loci of the HLA region in South American Indian tribes. Tissue Antigens (1997) 0.89
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4. Hum Immunol (1990) 0.89
Evolution of HLA-class I compared to HLA-class II polymorphism in Terena, a South-American Indian tribe. Hum Immunol (1999) 0.89
HL-A antigens in mummified pre-Columbian tissues. Science (1974) 0.89
A comparison of two levels of family-aided assertive community treatment. Psychiatr Serv (1996) 0.88
DQA1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol (1994) 0.88
Stimulation of gamma-globulin synthesis and specific antibody production by a factor released by activated lymphocytes. J Immunol (1973) 0.87
HLA class II DNA typing in two Brazilian populations. Tissue Antigens (1993) 0.87
Role of MICA in the immune response to transplants. Tissue Antigens (2010) 0.86
Comparisons of dialysis and transplant results from one center. Transplant Proc (1979) 0.86
Homologous disease in the adult rat, a model for autoimmune disease. II. Findings in the joints, heart, and other tissues. J Exp Med (1965) 0.86
Associations between HLA class II alleles in a North Indian population. Tissue Antigens (1998) 0.86
Diversity of HLA-DR2 in North Indians: the changed scenario after the discovery of DRB1*1506. Tissue Antigens (1998) 0.86
Gender differences in cognition in schizophrenia. Schizophr Res (1992) 0.85
Role of HLA-B and C alleles in development of psoriasis in patients from North India. Tissue Antigens (1998) 0.85
HLA-DPB1*0301 is a major risk factor for rheumatoid factor-negative adult rheumatoid arthritis. Arthritis Rheum (1991) 0.84
Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP. Int J Immunogenet (2007) 0.84
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. II. Typing for alleles of the DRw52-associated group. Hum Immunol (1990) 0.84
Memory deficits and anticholinergic levels in chronic schizophrenia. Am J Psychiatry (1986) 0.84
Restriction fragment length polymorphism of the human T cell receptor alpha gene. I. Two polymorphic restriction sites localized to different regions of the gene. Immunogenetics (1987) 0.84
Antigen-specific HLA-restricted human T-cell lines. II. A GAT-specific T-cell line restricted by a determinant carried by an HLA-DQ molecule. Immunogenetics (1984) 0.83
Comparison of HLA class II alleles in Gypsy and Czech populations by DNA typing with oligonucleotide probes. Tissue Antigens (1992) 0.83
Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation. Immunogenetics (1985) 0.83
Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J Rheumatol (1991) 0.83
Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR. Immunogenetics (1984) 0.83
DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group. Hum Immunol (1991) 0.82
Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury. J Clin Invest (1981) 0.82
Eight groups of human endothelial cell alloantigens. Tissue Antigens (1976) 0.82
Antigens in human monocytes. III. Use of monocytes in typing for HLA-D related (DR) antigens. Transplant Proc (1978) 0.82
Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate specific and reliable. Tissue Antigens (2000) 0.81
Immunological memory to an autoantigen: the in vitro response to thyroglobulin. Clin Exp Immunol (1967) 0.81
Correlation between anti-RANA and anti-EBNA titers in normal subjects with and without HLA-DRw4. Arthritis Rheum (1980) 0.81
Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol (2000) 0.81